Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies

AW Lemstra, MH De Beer, CE Teunissen… - Journal of Neurology …, 2017 - jnnp.bmj.com
Objective To investigate whether concomitant Alzheimer's disease (AD) pathology, reflected
by cerebrospinal fluid (CSF) biomarkers, has an impact on dementia with Lewy bodies …

Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage

O Bousiges, S Bombois, S Schraen… - Journal of Neurology …, 2018 - jnnp.bmj.com
Background Differential diagnosis between dementia with Lewy bodies (DLB) and
Alzheimer's disease (AD) is not straightforward, especially in the early stages of disease. We …

The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia

M Andersson, H Zetterberg, L Minthon… - … journal of geriatric …, 2011 - Wiley Online Library
Abstract Objective Dementia with Lewy bodies (DLB) and Parkinson's disease dementia
(PDD) may be viewed as different points on a continuum reflecting the regional burden and …

EEG characteristics of dementia with Lewy bodies, Alzheimer's disease and mixed pathology

JJ Van der Zande, AA Gouw… - Frontiers in aging …, 2018 - frontiersin.org
Introduction: Previous studies on electroencephalography (EEG) to discriminate between
dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) have been promising …

Differences in clinical course between dementia with Lewy bodies and Alzheimer's disease

H Hanyu, T Sato, K Hirao, H Kanetaka… - European Journal of …, 2009 - Wiley Online Library
Background and purpose: To investigate whether there may be differences in the clinical
course and changes in cognitive progression between dementia with Lewy bodies (DLB) …

Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort study

Z Walker, I McKeith, J Rodda, T Qassem, K Tatsch… - BMJ open, 2012 - bmjopen.bmj.com
Objectives Dementia with Lewy bodies (DLB) accounts for 10%–15% of dementia cases at
autopsy and has distinct clinical features associated with earlier institutionalisation and a …

Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies

M Van de Beek, R Babapour Mofrad… - Alzheimer's research & …, 2020 - Springer
Abstract Background Dementia with Lewy bodies (DLB) is more prevalent in men than in
women. In addition, post-mortem studies found sex differences in underlying pathology. It …

Improving the identification of dementia with Lewy bodies in the context of an Alzheimer's-type dementia

AJ Thomas, F Mahin-Babaei, M Saidi, D Lett… - Alzheimer's research & …, 2018 - Springer
Abstract Background Dementia due to Alzheimer's disease (AD) and dementia with Lewy
bodies (DLB) are the two most common neurodegenerative causes of dementia. They …

Long-term cognitive outcome of Alzheimer's disease and dementia with Lewy bodies: dual disease is worse

F Blanc, R Mahmoudi, T Jonveaux, J Galmiche… - Alzheimer's research & …, 2017 - Springer
Background Longitudinal studies of dementia with Lewy bodies (DLB) are rare. Clinically,
DLB is usually considered to worsen into Alzheimer's disease (AD). The aim of our study …

Biomarkers in dementia with Lewy bodies: a review

N Sinha, M Firbank, JT O'Brien - International journal of geriatric …, 2012 - Wiley Online Library
Background Dementia with Lewy bodies (DLB) shares common clinical, neuropsychological
and pathological features with other dementia subtypes, such as Alzheimer's disease (AD) …